151 related articles for article (PubMed ID: 20632100)
1. Antiglycan antibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Drygiannakis D; Tsirogianni A; Oustamanolakis P; Karmiris K; Papamichael K; Mantzaris GJ; Kouroumalis EA
Dig Dis Sci; 2011 Mar; 56(3):845-52. PubMed ID: 20632100
[TBL] [Abstract][Full Text] [Related]
2. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
3. Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease.
Simondi D; Mengozzi G; Betteto S; Bonardi R; Ghignone RP; Fagoonee S; Pellicano R; Sguazzini C; Pagni R; Rizzetto M; Astegiano M
Inflamm Bowel Dis; 2008 May; 14(5):645-51. PubMed ID: 18240283
[TBL] [Abstract][Full Text] [Related]
4. The Correlation between New Serological Markers and Disease Phenotype and Activation in Inflammatory Bowel Disease.
Yorulmaz E; Adalı G; Yorulmaz H; Taşan G; Gürses S; Ayaş MR; Tuncer İ
Middle East J Dig Dis; 2022 Jul; 14(3):294-303. PubMed ID: 36619271
[No Abstract] [Full Text] [Related]
5. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
6. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
Goren I; Yahav L; Tulchinsky H; Dotan I
Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
[TBL] [Abstract][Full Text] [Related]
7. New serologic markers for inflammatory bowel disease diagnosis.
Dotan I
Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866
[TBL] [Abstract][Full Text] [Related]
8. Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.
Ben-Shachar S; Finezilber Y; Elad H; Rabinowitz K; Goren I; Isakov O; Yanai H; Dotan I
Inflamm Bowel Dis; 2019 Jan; 25(2):336-344. PubMed ID: 30265311
[TBL] [Abstract][Full Text] [Related]
9. New serological biomarkers of inflammatory bowel disease.
Li X; Conklin L; Alex P
World J Gastroenterol; 2008 Sep; 14(33):5115-24. PubMed ID: 18777587
[TBL] [Abstract][Full Text] [Related]
10. Starch Consumption May Modify Antiglycan Antibodies and Fecal Fungal Composition in Patients With Ileo-Anal Pouch.
Goren I; Godny L; Reshef L; Yanai H; Gophna U; Tulchinsky H; Dotan I
Inflamm Bowel Dis; 2019 Mar; 25(4):742-749. PubMed ID: 30535148
[TBL] [Abstract][Full Text] [Related]
11. Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy.
Sładek M; Wasilewska A; Swiat A; Cmiel A
Prz Gastroenterol; 2014; 9(4):232-41. PubMed ID: 25276255
[TBL] [Abstract][Full Text] [Related]
12. Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort.
Malickova K; Lakatos PL; Bortlik M; Komarek V; Janatkova I; Lukas M
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):144-50. PubMed ID: 19927001
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease serology in Asia and the West.
Prideaux L; Kamm MA; De Cruz P; van Langenberg DR; Ng SC; Dotan I
World J Gastroenterol; 2013 Oct; 19(37):6207-13. PubMed ID: 24115818
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study.
Yao F; Fan Y; Lv B; Ji C; Xu L
Medicine (Baltimore); 2018 Aug; 97(32):e11772. PubMed ID: 30095633
[TBL] [Abstract][Full Text] [Related]
15. Evaluating IBD-specific antiglycan antibodies in serum of patients with spondyloarthritis and rheumatoid arthritis: are they really specific?
Aloush V; Dotan I; Ablin JN; Elkayam O
Clin Exp Rheumatol; 2019; 37(1):32-36. PubMed ID: 29998822
[TBL] [Abstract][Full Text] [Related]
16. [Relevance of serologic studies in inflammatory bowel diseases].
Papp M; Altorjay I; Lakatos PL
Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-glycan antibodies predict complicated Crohn's disease behavior: a cohort study.
Rieder F; Schleder S; Wolf A; Dirmeier A; Strauch U; Obermeier F; Lopez R; Spector L; Fire E; Yarden J; Rogler G; Dotan N; Klebl F
Inflamm Bowel Dis; 2010 Aug; 16(8):1367-75. PubMed ID: 20024902
[TBL] [Abstract][Full Text] [Related]
18. α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease.
Manolakis AC; Christodoulidis G; Kapsoritakis AN; Georgoulias P; Tiaka EK; Oikonomou K; Valotassiou VJ; Potamianos SP
World J Gastroenterol; 2017 Jan; 23(3):437-446. PubMed ID: 28210079
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
[TBL] [Abstract][Full Text] [Related]
20. Serological markers of inflammatory bowel disease.
Kuna AT
Biochem Med (Zagreb); 2013; 23(1):28-42. PubMed ID: 23457764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]